Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
The management of urolithiasis represents a common and costly problem for healthcare services. Up to 15% of the general population may be affected at some point in their lives and 25–50% of cases will recur.1 ,2 While minimally invasive surgical treatments can treat most of the upper tract calculi, acute stone events and surgical treatment persist as a significant source of morbidity for patients with recurrent urolithiasis. Consequently, the prevention of stone recurrence is an appealing strategy. Although the benefit of dietary modification in preventing stone formation has long been recognised,3 drug treatments have been shown to provide additional protection beyond that of dietary measures alone.4 The goal …
Competing interests None.